Edgewise Therapeutics, Inc. — Director's Dealing 2021

Dec 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edgewise Therapeutics, Inc. (EWTX)
CIK: 0001710072
Period of Report: 2021-11-30

Reporting Person: Russell Alan J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-30	Common Stock	M	147585.00	$0.18	Acquired	147585.00	Direct
2021-11-30	Common Stock	M	25000.00	$0.45	Acquired	172585.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-30	Stock Option (Right to Buy)	$0.18	M	147585.00	Disposed	2027-08-08	Common Stock (147585.00)	Direct
2021-11-30	Stock Option (Right to Buy)	$0.45	M	25000.00	Disposed	2028-08-30	Common Stock (25000.00)	Direct

Footnotes

F1: 1/4th of the shares subject to the option vested on July 27, 2018 and 1/48th of the shares subject to the option vested each month thereafter.

F2: 1/48th of the shares subject to the option vested on September 10, 2018 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.